Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology.
about
Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic.Calpain: a molecule to induce AIF-mediated necroptosis in RGC-5 following elevated hydrostatic pressureSNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone.Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness?E2F1 in neurons is cleaved by calpain in an NMDA receptor-dependent manner in a model of HIV-induced neurotoxicity.Mitochondrial Ca(2+) and neurodegenerationMacroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutationDoes mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.β Cell-specific increased expression of calpastatin prevents diabetes induced by islet amyloid polypeptide toxicity.Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.Drug targets from genetics: α-synuclein.Mitochondrial metabolic control of microtubule dynamics impairs the autophagic pathway in Parkinson's disease.Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like PropagationBaicalein prevents 6-OHDA/ascorbic acid-induced calcium-dependent dopaminergic neuronal cell death.A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease.Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies.Mitochondrial fusion/fission, transport and autophagy in Parkinson's disease: when mitochondria get nasty.Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson's Disease.Postnatal calpain inhibition elicits cerebellar cell death and motor dysfunction.Mitochondrial dysfunction in Parkinson's disease
P2860
Q30525658-C8943C4D-B0A2-4540-A9C8-111C00D6CB93Q33621894-8CF940F8-8868-4959-AD57-424610735FB8Q33686439-B1365DC9-B25A-4A83-8DD1-E47888446668Q33828400-676E1BC0-50D1-4900-ABFB-EA1EB2E484F5Q35177482-0B456ED7-293F-44FD-9FA9-0EB9C358D309Q36095330-9F02F153-4A38-4C5B-BF89-4492DA78D2B8Q36424977-21409A4B-1065-4217-9A1A-9E187F84B3F3Q36813613-F7AF73D0-EA41-4E5E-A0C2-6C63757A5AF0Q37377099-0CE00DB5-99BC-4D17-854D-1FEB974E06F9Q37767600-D95B3990-9DC9-4D8C-B30E-A6AD38A4ECF7Q37916635-C3D7C36C-A9C0-4A60-A245-9BFAC08E7470Q37966705-AD3C2E69-C51A-4FE8-80BA-FABFB46082F7Q38303579-5BF0DAEA-FC82-4854-85F6-6109E8E5F16BQ38615356-16BC939E-D9FD-4693-AD9C-9A3522822AD0Q38915128-8D014F41-F060-4085-AA34-E302206D5839Q39109344-AE05FEC2-8216-4DD1-9FC0-BE3C7FFDAC02Q41850035-BAE1537A-0C8B-4845-8664-E60C3F081BD2Q42580316-6FEE972C-E9B8-4E86-B922-050452E15635Q46839158-6283C474-6BB8-4E81-88F2-49CCD2C4FC7CQ47121498-E397C6B1-4EA8-40A9-8348-ADDC06FF5C8DQ58693945-92A4DB19-8178-4A9C-8ACF-9A1F4159753F
P2860
Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Dysfunctional mitochondria uph ...... Parkinson's disease pathology.
@en
Dysfunctional mitochondria uph ...... Parkinson's disease pathology.
@nl
type
label
Dysfunctional mitochondria uph ...... Parkinson's disease pathology.
@en
Dysfunctional mitochondria uph ...... Parkinson's disease pathology.
@nl
prefLabel
Dysfunctional mitochondria uph ...... Parkinson's disease pathology.
@en
Dysfunctional mitochondria uph ...... Parkinson's disease pathology.
@nl
P50
P921
P1476
Dysfunctional mitochondria uph ...... Parkinson's disease pathology.
@en
P2093
A Raquel Esteves
P304
P356
10.1016/J.NBD.2009.12.011
P577
2009-12-23T00:00:00Z